163 related articles for article (PubMed ID: 10814518)
1. Surface expression of the cystic fibrosis transmembrane conductance regulator mutant DeltaF508 is markedly upregulated by combination treatment with sodium butyrate and low temperature.
Heda GD; Marino CR
Biochem Biophys Res Commun; 2000 May; 271(3):659-64. PubMed ID: 10814518
[TBL] [Abstract][Full Text] [Related]
2. Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network.
Lipecka J; Norez C; Bensalem N; Baudouin-Legros M; Planelles G; Becq F; Edelman A; Davezac N
J Pharmacol Exp Ther; 2006 May; 317(2):500-5. PubMed ID: 16424149
[TBL] [Abstract][Full Text] [Related]
3. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator.
Namkung W; Kim KH; Lee MG
Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability.
Clancy JP; Hong JS; Bebök Z; King SA; Demolombe S; Bedwell DM; Sorscher EJ
Biochemistry; 1998 Oct; 37(43):15222-30. PubMed ID: 9790686
[TBL] [Abstract][Full Text] [Related]
5. Low temperature induces the delivery of mature and immature CFTR to the plasma membrane.
Rennolds J; Boyaka PN; Bellis SL; Cormet-Boyaka E
Biochem Biophys Res Commun; 2008 Feb; 366(4):1025-9. PubMed ID: 18096515
[TBL] [Abstract][Full Text] [Related]
6. Dynasore inhibits removal of wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) from the plasma membrane.
Young A; Gentzsch M; Abban CY; Jia Y; Meneses PI; Bridges RJ; Bradbury NA
Biochem J; 2009 Jul; 421(3):377-85. PubMed ID: 19442237
[TBL] [Abstract][Full Text] [Related]
7. Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones.
Wang Y; Bartlett MC; Loo TW; Clarke DM
Mol Pharmacol; 2006 Jul; 70(1):297-302. PubMed ID: 16624886
[TBL] [Abstract][Full Text] [Related]
8. Rescue of DeltaF508 and other misprocessed CFTR mutants by a novel quinazoline compound.
Loo TW; Bartlett MC; Clarke DM
Mol Pharm; 2005; 2(5):407-13. PubMed ID: 16196493
[TBL] [Abstract][Full Text] [Related]
9. Misassembled mutant DeltaF508 CFTR in the distal secretory pathway alters cellular lipid trafficking.
Gentzsch M; Choudhury A; Chang XB; Pagano RE; Riordan JR
J Cell Sci; 2007 Feb; 120(Pt 3):447-55. PubMed ID: 17213331
[TBL] [Abstract][Full Text] [Related]
10. Mild processing defect of porcine DeltaF508-CFTR suggests that DeltaF508 pigs may not develop cystic fibrosis disease.
Liu Y; Wang Y; Jiang Y; Zhu N; Liang H; Xu L; Feng X; Yang H; Ma T
Biochem Biophys Res Commun; 2008 Aug; 373(1):113-8. PubMed ID: 18555011
[TBL] [Abstract][Full Text] [Related]
11. Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting.
Bruscia E; Sangiuolo F; Sinibaldi P; Goncz KK; Novelli G; Gruenert DC
Gene Ther; 2002 Jun; 9(11):683-5. PubMed ID: 12032687
[TBL] [Abstract][Full Text] [Related]
12. Curcumin enhances cystic fibrosis transmembrane regulator expression by down-regulating calreticulin.
Harada K; Okiyoneda T; Hashimoto Y; Oyokawa K; Nakamura K; Suico MA; Shuto T; Kai H
Biochem Biophys Res Commun; 2007 Feb; 353(2):351-6. PubMed ID: 17178109
[TBL] [Abstract][Full Text] [Related]
13. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
[TBL] [Abstract][Full Text] [Related]
14. Trafficking of immature DeltaF508-CFTR to the plasma membrane and its detection by biotinylation.
Luo Y; McDonald K; Hanrahan JW
Biochem J; 2009 Apr; 419(1):211-9, 2 p following 219. PubMed ID: 19053947
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.
Dormer RL; Harris CM; Clark Z; Pereira MM; Doull IJ; Norez C; Becq F; McPherson MA
Thorax; 2005 Jan; 60(1):55-9. PubMed ID: 15618584
[TBL] [Abstract][Full Text] [Related]
16. Molecular dissection of the butyrate action revealed the involvement of mitogen-activated protein kinase in cystic fibrosis transmembrane conductance regulator biogenesis.
Sugita M; Kongo H; Shiba Y
Mol Pharmacol; 2004 Nov; 66(5):1248-59. PubMed ID: 15304546
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
18. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.
Cormet-Boyaka E; Jablonsky M; Naren AP; Jackson PL; Muccio DD; Kirk KL
Proc Natl Acad Sci U S A; 2004 May; 101(21):8221-6. PubMed ID: 15141088
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
[TBL] [Abstract][Full Text] [Related]
20. S-nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells.
Zaman K; Carraro S; Doherty J; Henderson EM; Lendermon E; Liu L; Verghese G; Zigler M; Ross M; Park E; Palmer LA; Doctor A; Stamler JS; Gaston B
Mol Pharmacol; 2006 Oct; 70(4):1435-42. PubMed ID: 16857740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
